Business Wire

The Marriott Vacation Clubs™ Expands in Asia Pacific with New Resort in Khao Lak, Thailand and Growth in Bali and Shanghai

28.8.2025 15:00:00 CEST | Business Wire | Press Release

Share

The Marriott Vacation Clubs™, a collection of vacation ownership brands under Marriott Vacations Worldwide Corporation, is expanding its presence in Asia Pacific with the opening of Marriott Vacation Club, Khao Lak Beach Resort in Thailand this August. The new resort is part of broader regional growth, that includes a new development at Marriott’s Enclave at Bali Nusa Dua Terrace and new apartments at Marriott’s Bali Nusa Dua Terrace, as well as the expansion of The Marriott Vacation Club’s marketing call center in Shanghai.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827472037/en/

Marriott Vacation Club, Khao Lak Beach Resort provides scenic views of the Andaman Sea. Photograph depicts the JW Marriott, Khao Lak Resort & Spa.

“Our continued investment in Asia Pacific, including the opening of new resorts and the expansion of our call center operations, reflects our long-term commitment to the region,” said John Geller, president and CEO of Marriott Vacations Worldwide. “As interest in vacation ownership continues to rise among Asian travelers and international Owners and Members alike, we’re excited to deepen our presence and deliver exceptional experiences that blend cultural richness with the trusted quality of The Marriott Vacation Clubs portfolio.”

Introduction of Marriott Vacation Club, Khao Lak Beach Resort

In August 2025, The Marriott Vacation Clubs will debut its newest destination: Marriott Vacation Club, Khao Lak Beach Resort. Located within the stunning JW Marriott Khao Lak Resort & Spa, just 90 minutes from Phuket International Airport, 52 Family Suites are being thoughtfully transformed into spacious 2-bedroom vacation ownership apartments offering four distinct room types. Designed to comfortably host up to five guests, each apartment blends the warmth of Southern Thai-inspired architecture with traditional furnishings and locally influenced artwork. Perfect for extended stays, the accommodations will feature spacious living and dining areas and cozy bedrooms.

The architecture at the new resort takes cues from a traditional Lanna-style farmhouse, showcasing teak details, simple gabled roofs, warm wood paneling, and wide-open verandahs framing views of the Khao Lak mountains. Here, Owners, Members and guests will have access to JW Marriott Khao Lak Resort & Spa’s garden, part of the resort’s commitment to a sustainable future. The JW Garden supplies the resort with fresh, organic produce, cultivating more than 200 varieties of fruits, vegetables and herbs used across its restaurants. Guests can also take part in hands-on classes and workshops focused on farming, sustainability and well-being. Sustainability is further woven into the guest experience at Marriott Vacation Club, Khao Lak Beach Resort with initiatives designed to reduce environmental impact. Efforts include the elimination of single-use plastics throughout the resort, the use of reusable glass water bottles in guest rooms, and bamboo key cards as a natural, biodegradable alternative to plastic.

As part of the JW Marriott Khao Lak Resort & Spa campus, Owners, Members and guests at Marriott Vacation Club, Khao Lak Beach Resort will also enjoy a range of amenities, including an impressive one-and-a-half-mile lagoon swimming pool, the largest in Southeast Asia, a kids' pool, 11 restaurants and pool bars, and, in late 2026, pickleball and basketball courts, adventure golf, and bicycles for exploring the area are anticipated to be available.

“Thailand is experiencing a major tourism resurgence, driven by forward-thinking government initiatives such as visa-free entry, increased flight access, a national campaign promoting travel, and renewed global interest sparked by recent film productions taking place here. Interest in the country’s diverse destinations is soaring,” said Lee Dowling, senior vice president and managing director, Asia Pacific, Europe and Middle East. "The debut of Marriott Vacation Club, Khao Lak Beach Resort marks a timely and strategic expansion for The Marriott Vacation Clubs, as we continue to meet growing demand from our Owners, Members and guests for enriching vacation experiences in Asia Pacific. With its beaches, rich cultural heritage, and rising profile as a leisure destination, Khao Lak is a natural fit for the kind of immersive stays our Owners and Members expect.”

Construction of additional apartments began in March with a ceremonial groundbreaking featuring a Brama ritual and Thai monk blessing ceremony to honor and bless the land. Additionally, a new sales gallery will open in early 2026. Designed to deliver a fully immersive experience, the space will introduce guests to the world of vacation ownership through an engaging showcase of the brand’s global portfolio and diverse destinations. This space will also showcase Thai design elements, such as lush tropical greenery, and a refined palette of warm neutrals, celadon green, and soft blue-greys to evoke a sense of place. Reservations are now open for future rental stays on www.MarriottVacationClubs.com, and Owners and Members in Abound by Marriott Vacations™ can use Club Points to reserve stays now with check-ins beginning August 28, 2025.

Continued Growth in Bali Vacation Offerings

The Marriott Vacation Clubs plans to unveil 32 new apartments as part of the Marriott’s Bali Nusa Dua Terrace expansion in early 2026. The new accommodations include 16 one-bedroom and 16 two-bedroom apartments, all featuring fully equipped kitchens and private plunge pools. Owners, Members and guests will also enjoy access to a 2,200-square-foot swimming pool and a 4,500-square-foot sun deck, with a pool bar and private cabanas.

Additionally, the brand will open Marriott’s Enclave at Bali Nusa Dua Terrace next year within the current Marriott’s Bali Nusa Dua Terrace property. The standalone, two-story apartments will include 13 two-bedroom and 13 three-bedroom units, each with a private pool and kitchen. Marriott’s Enclave at Bali Nusa Dua Terrace will also feature a dedicated lobby/check-in area, kids’ club, fitness studio, pool bar, and Owners lounge.

Owners, Members, and guests at both properties will have full access to amenities and facilities at the co-located Renaissance Bali Nusa Dua Resort. This includes access to five food and beverage venues, a pool, full-service spa, and fitness center.

Expansion of Call Center Operations in Shanghai

The Marriott Vacation Clubs is expanding its Shanghai marketing call center and officially opened the new office in summer 2025 with a larger workforce, growing from 80 to 125 associates to support increased demand among Chinese Owners, Members and vacationers. The call center provides dedicated marketing and engagement support, playing a key role in strengthening relationships across the region.

To learn more about The Marriott Vacation Clubs please visit www.MarriottVacationClubs.com.

About The Marriott Vacation Clubs™

The Marriott Vacation Clubs™ is a part of Marriott Vacations Worldwide Corporation, and is a portfolio of industry leading vacation ownership brands with over 90 properties collectively throughout the U.S., Caribbean, Mexico, Central America, Europe, Asia, and Australia, including the Marriott Vacation Club®, Sheraton® Vacation Club, and Westin® Vacation Club brands. Owners, Members and guests can enjoy year-round access to some of the best vacation destinations with villa-style accommodations. The Marriott Vacation Clubs’ point-based vacation ownership programs provide Owners, Members, and their families with the flexibility to enjoy high-quality vacation experiences. Follow The Marriott Vacation Clubs on FB/IG: @MarriottVacationClub, @SheratonVacationClub, @WestinVacationClub or TikTok @themarriottvacationclubs.

About Marriott Vacations Worldwide Corporation

Marriott Vacations Worldwide Corporation is a leading global vacation Company that offers vacation ownership, exchange, rental and resort and property management, along with related businesses, products, and services. The Company has approximately 120 vacation ownership resorts and approximately 700,000 owner families in a diverse portfolio that includes some of the most iconic vacation ownership brands. The Company also operates exchange networks and membership programs comprised of more than 3,200 affiliated resorts in over 90 countries and territories and provides management services to other resorts and lodging properties. As a leader and innovator in the vacation industry, the Company upholds the highest standards of excellence in serving its customers, investors and associates while maintaining exclusive, long-term relationships with Marriott International, Inc. and an affiliate of Hyatt Hotels Corporation for the development, sales and marketing of vacation ownership products and services. For more information, visit www.marriottvacationsworldwide.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250827472037/en/

Contacts

Neal Goldner
Investor Relations
IR@mvwc.com

Cameron Klaus
Global Communications
407-206-6300
media@mvwc.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye